Fortis Healthcare Q4 FY26 Revenue up 17.8% to ₹2,365 Cr, PAT surges 44.2% to ₹271 Cr; Recommends Dividend
Fortis Healthcare reported Q4 FY26 consolidated revenue of ₹2,365 Cr, up 17.8% YoY. PAT surged 44.2% to ₹271 Cr. For FY26, revenue grew 17.3% to ₹9,128 Cr, and PAT rose 31.5% to ₹1,064 Cr. The board recommended a dividend of ₹1 per share. The company also completed acquisitions and expanded its network.
The announcement includes significant financial performance improvements and a dividend declaration, which are key factors that directly influence investor sentiment and stock valuation.
The company reported strong year-on-year growth in revenue and profit for both the quarter and the full financial year. The recommendation of a dividend also signals financial health and a commitment to shareholder returns.
Fortis Healthcare Limited announced its audited consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported a consolidated revenue of ₹2,365 crore for Q4 FY26, an increase of 17.8% compared to ₹2,007 crore in Q4 FY25. Operating EBITDA saw a rise of 22.2% to ₹531 crore, with margins improving to 22.5% from 21.7% in the prior year period. Profit After Tax (PAT) surged by 44.2% to ₹271 crore from ₹188 crore in Q4 FY25.
For the full financial year FY26, consolidated revenues reached ₹9,128 crore, up 17.3% from ₹7,783 crore in FY25. Operating EBITDA grew by 31.3% to ₹2,085 crore, with margins expanding to 22.8% from 20.4% in FY25. PAT for FY26 increased by 31.5% to ₹1,064 crore from ₹809 crore in FY25.
The Board of Directors has recommended a dividend of ₹1 per share (10% of face value), subject to shareholders' approval. The company's hospital business revenue grew by 19.0% to ₹2,023 crore in Q4 FY26, while the diagnostics business reported gross revenues of ₹387 crore. The company also highlighted strategic acquisitions and expansions during the year, including the acquisition of People Tree Hospital in Bengaluru and Shrimann Hospital in Punjab, and the long-term lease for the Greater Noida Hospital.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.